Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Zorsky Pe"'
Autor:
John W. Hiemenz, O. F. Ballester, Zorsky Pe, Todd Mattox, Karen K. Fields, Dimitrios P. Agaliotis, G. J. Elfenbein, Janelle Perkins, Raquel Rosen, Steven C. Goldstein
Publikováno v:
The American Journal of the Medical Sciences. 314:292-298
The objective of this study was to evaluate nephrotoxicity in adult patients treated with high-dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell transplantation. We conducted a retrospective analysis of clinical and laborat
Publikováno v:
Journal of Clinical Oncology. 12:544-552
PURPOSE To conduct a phase I/II evaluation of the combination of ifosfamide, carboplatin, and etoposide (ICE) to determine toxicity and activity in a variety of refractory malignancies. PATIENTS AND METHODS Two hundred four patients, 13 to 64 years o
Autor:
William E. Janssen, Zorsky Pe, Karen K. Fields, John W. Hiemenz, G. J. Elfenbein, Lori E. Kronish, M.C. Machak, J.P. Perkins
Publikováno v:
Surgical Oncology. 2:87-95
We have recently treated 66 women with breast cancer with escalating doses of ifosfamide, carboplatin, and etoposide (ICE) followed by autologous stem cell rescue (ASCR). Patients received ifosfamide (6000-24,000 mg m-2), carboplatin (1200-2100 mg m-
Autor:
Karen K. Fields, R Tummala, William E. Janssen, G. J. Elfenbein, Daniel M. Sullivan, Zorsky Pe, Raquel Rosen, Steven C. Goldstein, O. F. Ballester, R. A. Saez, John W. Hiemenz, Robert Sackstein, Janelle Perkins
Publikováno v:
Bone marrow transplantation. 20(8)
Six patients with multiple myeloma and chronic renal insufficiency (serum creatinine >3.0 mg/dl), including four on dialysis, received high-dose busulfan and cyclophosphamide (BUCY) followed by autologous peripheral stem cell transplantation. Periphe
Autor:
Lori E. Kronish, P. Sullivan, O. F. Ballester, Steven C. Goldstein, Zorsky Pe, Karen K. Fields, Lynn C. Moscinski, A. S. D. Spiers, H. I. Saba, John W. Hiemenz, G. J. Elfenbein
Publikováno v:
British journal of haematology. 96(4)
We evaluated toxicities and responses to a novel, dose intensive and time sequenced, chemotherapy programme (DC-IE) in 45 patients with high-risk myeloma. DC-IE consisted of: dexamethasone (days 1-4); cyclophosphamide (day 5); idarubicin and etoposid
Autor:
John H. Hiemenz, William E. Janssen, O. F. Ballester, Richard J. Creger, Zorsky Pe, Janelle Perkins, Karen K. Fields, Brenda W. Cooper, Hillard M. Lazarus, Gerald J. Elfenbein
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 13(2)
PURPOSE A phase I dose-escalation study of ifosfamide, carboplatin, and etoposide (ICE) with autologous stem-cell rescue (ASCR) was conducted to determine the maximum-tolerated dose (MTD) of ICE given over 6 days. PATIENTS AND METHODS One hundred fif
Publikováno v:
Southern medical journal. 86(3)
Public opinion, the federal government, and financial constraints are demanding that the cost of medical care be controlled. Physicians are keenly aware of this problem. We believe that the contribution of fine needle aspiration to cost containment h
Autor:
Gary H. Lyman, Mary C. Machak, Karen K. Fields, Ramy A. Saleh, Zorsky Pe, Joanna T. Piazza, Janelle Perkins, Lori E. Kronish, G. J. Elfenbein, William E. Janssen, Theresa G. Saleh
Publikováno v:
Hematological oncology. 10(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.